THERAPEUTIC TRIALS IN CORONARY THROMBOSIS SHOULD MEASURE LEFT VENTRICULAR FUNCTION AS PRIMARY END-POINT OF TREATMENT

The Lancet

Volumn 331, Issue 8577, 1988, Pages 104-106

  Norris, RobinM ^a   White, HarveyD ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE;

CORONARY ARTERY THROMBOSIS; HEART LEFT VENTRICLE PERFORMANCE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; THEORETICAL STUDY;

CLINICAL TRIALS; CORONARY DISEASE; CORONARY THROMBOSIS; HUMAN; STREPTOKINASE; STROKE VOLUME; SUPPORT, NON-U.S. GOV'T;

EID: 0023840020     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)90295-4     Document Type: Article

References (27)

1. Clinical features of sudden obstruction of the coronary arteries
2. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction
3. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase
4. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
5. Intravenous streptokinase given within 0-4 hours of onset of myocardial infarction reduced mortality rate in ISIS 2
6. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction
7. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM) mortality morbidity and infarct size at 21 days
8. The thrombolysis in myocardial infarction (TIMI) Trial Phase I findings
9. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction
10. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction. ISIS-1
11. Metoprolol in acute myocardial infarction (MIAMI) A randomised placebo-controlled international trial
12. Glucose-insulin-potassium following successful coronary reperfusion improves survival during myocardial infarction
13. Effects of preservation of left ventricular function after thrombolysis in acute myocardial infarction on human superoxide dismutase activity
14. Mortality from a coronary-care unit analysed by a new coronary prognostic index
15. Late hospital mortality following myocardial infarction
16. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol
17. Improved survival after early thrombolysis m acute myocardial infarction
18. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction
19. Clinical biostatistics the other side of statistical significance, alpha, beta, delta, and the calculation of sample size
20. A new coronary prognostic index
21. Prognosis after myocardial infarction results of 15-year follow-up
22. Determinants of prognosis in survivors of myocardial infarction A prospective clinical angiographic study
23. Prognosis after recovery from first acute Myocardial infarction determinants of reinfarction and sudden death
24. Left ventricular end-systolic volume is the major determinant of survival after recovery from myocardial infarction
25. Left ventricular ejection fraction determined by radionuclide ventriculography in early stages of first transmural myocardial infarction
26. Late effects of acute infarct dilation on heart size. a two-dimensional echocardiographic study
27. The stunned myocardium prolonged post-ischemic ventricular dysfunction